ArticleFrontiers in neurology2025

Nilotinib and imatinib: potential candidates for treatment of dementia and Parkinson's disease through national health insurance data.

Jihun Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.